The aim of this study is to evaluate the occurrence of adverse events of special interest, long term effectiveness of lomitapide and to evaluate whether prescribers of lomitapide are following the screening and monitoring recommendations as specified in product labeling.
- Patient Population – Patients taking lomitapide.
- Sponsor — Aegerion
- Contact Information – (402) 384-2705, MPCHeartConsultantsResearch@nmhs.org
- View this study ClinicalTrials.gov